Active Ingredient Pegloticase
Active Ingredient Details
What is Pegloticase?
uricase covalently attached to polyethylene glycol, modifying 71% of amino groups & retaining 11% of activity without eliciting antibody response in mice or man; used for lowering serum uric acid
What is the usage for Pegloticase?
Pegloticase is used to treat gout which has not responded to the usual treatments. It works by lowering high levels of uric acid in your body. Increased uric acid in your body can cause gout.
How many products in the NDC database contain Pegloticase?
The NDC database has 3 products with the active ingredient Pegloticase. The following table lists all the products that have this active ingredient.
NDC Products with Pegloticase
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 75987-058 | Proprietary Name: Krystexxa | Pegloticase | Injection, Solution | Intravenous | Horizon Therapeutics Usa, Inc. | ACTIVE | |
| 75987-080 | Proprietary Name: Krystexxa | Pegloticase | Injection, Solution | Intravenous | Horizon Therapeutics Usa, Inc. | ACTIVE | |
| 84606-6824 | Proprietary Name: | Pegloticase | Solution | Bio-technology General (israel) Ltd. | ACTIVE |
